Central Vein Stenosis Due to Dialysis Catheter Insertion in Subclavian Compared to Jugular Vein

Recruiting N/A Interventional Study
Subclavian Vein Stenosis Jugular Vein Occlusion
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
100 (estimated)
Sponsor
Skane University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Central vein stenosis (CVS) is a well-known complication of central venous catheterization, especially after insertion of temporary hemodialysis catheters (tHDC). Incidence and prevalence differ between studies, and exact figures are hard to tell since proper venographies seldom are performed unless the patient is symptomatic. Most tHDC are placed in the jugular or femoral veins as catheters in t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults (18 years of age or older). * In need of a tCDC with an expected treatment time of at least 7 days. * Informed consent. Exclusion Criteria: * Intravenous pacemaker or a PICC-line via right-sided central veins in situ. * Known right-sided CVS. * AV fistula on the right…
Contacts

Ola Borgquist, MD, PhD

+46704156334

oborgquist@gmail.com

CONTACT

Thomas Kander, MD, PhD

thomas.kander@med.lu.se

CONTACT